Extracellular vesicles (EVs) have been found to have the characteristics of their parent cells.
Based on the characteristics of these EVs, various studies on disease treatment using …

Osteoarthritis (OA) is the most common disabling joint disease with no effective disease
modifying drugs. Extracellular vesicles released by several types of mesenchymal stem cells …

Osteoarthritis (OA) is a degenerative disease that significantly impairs quality of life. There is
a pressing need for innovative OA therapies. While small extracellular vesicles (sEVs) show …

Osteoarthritis (OA) is a degenerative illness that greatly impacts the life quality of patients.
Currently, the therapeutic approaches for OA are very limited in clinical. The extracellular …

Osteoarthritis (OA) is a common degenerative joint disease which currently lacks of effective
agents. It is therefore urgent and necessary to seek an effective approach that can inhibit …

The main strategy of tissue repair and regeneration focuses on the application of
mesenchymal stem cells and cell-based nanoparticles, but there are still multiple challenges …

Osteoarthritis (OA) is a worldwide and disabling disease, which cause severe pain and
heavy socioeconomic burden. However, pharmacologic or surgical therapies cannot …

Developing effective methods for alveolar bone defect regeneration is a significant
challenge in orthopedics. Exosomes from human umbilical cord mesenchymal stem cells …

Osteoarthritis (OA) is a degenerative joint disease involving cartilage. Exosomes derived
from Mesenchymal stem cells (MSCs) therapy improves articular cartilage repair, but …

The therapeutic effects of extracellular vesicles (EVs) have been identified as a significant
factor in intercellular communication in different disease treatments, including osteoarthritis …